These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8206274)
1. A novel matrix-degrading protease in hormone-dependent breast cancer. Dickson RB; Shi YE; Johnson MD Biochem Soc Trans; 1994 Feb; 22(1):49-52. PubMed ID: 8206274 [No Abstract] [Full Text] [Related]
2. Stromal cell expression of components of matrix-degrading protease systems in human cancer. Hewitt R; Danø K Enzyme Protein; 1996; 49(1-3):163-73. PubMed ID: 8797004 [TBL] [Abstract][Full Text] [Related]
4. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Butler GS; Will H; Atkinson SJ; Murphy G Eur J Biochem; 1997 Mar; 244(2):653-7. PubMed ID: 9119036 [TBL] [Abstract][Full Text] [Related]
5. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Terada T; Okada Y; Nakanuma Y Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [TBL] [Abstract][Full Text] [Related]
7. Increased matrix metalloproteinase-2 activity induced by TGF-beta 1 in duct cells of human salivary gland is associated with the development of cyst formation in vivo. Azuma M; Tamatani T; Yuki T; Motegl K; Hoque MO; Yoshida H; Sato M J Oral Pathol Med; 1996 Oct; 25(9):467-73. PubMed ID: 8959553 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in bronchoalveolar lavage fluid following antigen challenge. Warner JA; Julius P; Luttmann W; Kroegel C Int Arch Allergy Immunol; 1997; 113(1-3):318-20. PubMed ID: 9130563 [No Abstract] [Full Text] [Related]
9. Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Lee KS; Rha SY; Kim SJ; Kim JH; Roh JK; Kim BS; Chung HC Clin Exp Metastasis; 1996 Nov; 14(6):512-9. PubMed ID: 8970581 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587 [TBL] [Abstract][Full Text] [Related]
11. The binding of gelatinases A and B to type I collagen yields both high and low affinity sites. Allan JA; Docherty AJ; Murphy G Ann N Y Acad Sci; 1994 Sep; 732():365-6. PubMed ID: 7978809 [No Abstract] [Full Text] [Related]
12. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693 [TBL] [Abstract][Full Text] [Related]
13. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Nuovo GJ; MacConnell PB; Simsir A; Valea F; French DL Cancer Res; 1995 Jan; 55(2):267-75. PubMed ID: 7812956 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase and tissue inhibitor of metalloproteinase regulation of the invasive potential of a metastatic renal cell line. McElligott AM; Baker AH; McGlynn H Biochem Soc Trans; 1997 Feb; 25(1):147S. PubMed ID: 9057045 [No Abstract] [Full Text] [Related]
15. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524 [TBL] [Abstract][Full Text] [Related]
16. Host expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in normal colon tissue affects metastatic potential of colorectal cancer. Masuda H; Aoki H Dis Colon Rectum; 1999 Mar; 42(3):393-7. PubMed ID: 10223763 [TBL] [Abstract][Full Text] [Related]
17. Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells. Noël AC; Polette M; Lewalle JM; Munaut C; Emonard HP; Birembaut P; Foidart JM Int J Cancer; 1994 Feb; 56(3):331-6. PubMed ID: 8314319 [TBL] [Abstract][Full Text] [Related]
18. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Hembry RM; Bagga MR; Reynolds JJ; Hamblen DL Ann Rheum Dis; 1995 Jan; 54(1):25-32. PubMed ID: 7880117 [TBL] [Abstract][Full Text] [Related]
19. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Torii K; Iida K; Miyazaki Y; Saga S; Kondoh Y; Taniguchi H; Taki F; Takagi K; Matsuyama M; Suzuki R Am J Respir Crit Care Med; 1997 Jan; 155(1):43-6. PubMed ID: 9001287 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of matrix metalloproteinase-2 activation in human breast cancer cell lines. Maiti SN; Yu M; Bueno J; Tirgari RH; Palao-Marco FL; Pulyaeva H; Thompson EW Ann N Y Acad Sci; 1994 Sep; 732():456-8. PubMed ID: 7978838 [No Abstract] [Full Text] [Related] [Next] [New Search]